1534 related articles for article (PubMed ID: 9321930)
21. Folic acid mediated attenuation of loss of heterozygosity of DCC tumor suppressor gene in the colonic mucosa of patients with colorectal adenomas.
Nagothu KK; Jaszewski R; Moragoda L; Rishi AK; Finkenauer R; Tobi M; Naumoff JA; Dhar R; Ehrinpreis M; Kucuk O; Majumdar AP
Cancer Detect Prev; 2003; 27(4):297-304. PubMed ID: 12893078
[TBL] [Abstract][Full Text] [Related]
22. Codon 201(Gly) polymorphic type of the DCC gene is related to disseminated neuroblastoma.
Kong XT; Choi SH; Bessho F; Kobayashi M; Hanada R; Yamamoto K; Hayashi Y
Neoplasia; 2001; 3(4):267-72. PubMed ID: 11571626
[TBL] [Abstract][Full Text] [Related]
23. ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition.
Herbst A; Bommer GT; Kriegl L; Jung A; Behrens A; Csanadi E; Gerhard M; Bolz C; Riesenberg R; Zimmermann W; Dietmaier W; Wolf I; Brabletz T; Göke B; Kolligs FT
Gastroenterology; 2009 Aug; 137(2):639-48, 648.e1-9. PubMed ID: 19394332
[TBL] [Abstract][Full Text] [Related]
24. Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction.
Cawkwell L; Lewis FA; Quirke P
Br J Cancer; 1994 Nov; 70(5):813-8. PubMed ID: 7947085
[TBL] [Abstract][Full Text] [Related]
25. Study of loss of heterozygosity at DCC and APC/MCC genetic loci of gastric cancer.
Wang D; Fang D; Luo Y; Lu R; Liu W
Chin Med Sci J; 1999 Jun; 14(2):107-11. PubMed ID: 12901620
[TBL] [Abstract][Full Text] [Related]
26. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer.
Kawana Y; Ichikawa T; Suzuki H; Ueda T; Komiya A; Ichikawa Y; Furuya Y; Akakura K; Igarashi T; Ito H
Prostate; 2002 Sep; 53(1):60-4. PubMed ID: 12210480
[TBL] [Abstract][Full Text] [Related]
27. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
28. High frequency of deletion on chromosome 9p21 may harbor several tumor-suppressor genes in human prostate cancer.
Perinchery G; Bukurov N; Nakajima K; Chang J; Li LC; Dahiya R
Int J Cancer; 1999 Nov; 83(5):610-4. PubMed ID: 10521795
[TBL] [Abstract][Full Text] [Related]
29. Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer.
Thompson AM; Morris RG; Wallace M; Wyllie AH; Steel CM; Carter DC
Br J Cancer; 1993 Jul; 68(1):64-8. PubMed ID: 8318422
[TBL] [Abstract][Full Text] [Related]
30. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q.
Yin Z; Babaian RJ; Troncoso P; Strom SS; Spitz MR; Caudell JJ; Stein JD; Kagan J
Oncogene; 2001 Apr; 20(18):2273-80. PubMed ID: 11402322
[TBL] [Abstract][Full Text] [Related]
31. Allelic loss and microsatellite instability in prostate cancers in Japan.
Watanabe M; Shiraishi T; Muneyuki T; Nagai M; Fukutome K; Murata M; Kawamura J; Yatani R
Oncology; 1998; 55(6):569-74. PubMed ID: 9778625
[TBL] [Abstract][Full Text] [Related]
32. Who takes the lead in the development of ulcerative colitis-associated colorectal cancers: mutator, suppressor, or methylator pathway?
Maia L; Dinis J; Cravo M; Claro I; Baltazar C; Fonseca I; Veloso T; Capelinha AF; Carneiro F; Nobre-Leitão C
Cancer Genet Cytogenet; 2005 Oct; 162(1):68-73. PubMed ID: 16157203
[TBL] [Abstract][Full Text] [Related]
33. Loss of two new loci on chromosome 8 (8p23 and 8q12-13) in human prostate cancer.
Perinchery G; Bukurov N; Nakajima K; Chang J; Hooda M; Oh BR; Dahiya R
Int J Oncol; 1999 Mar; 14(3):495-500. PubMed ID: 10024682
[TBL] [Abstract][Full Text] [Related]
34. Lymph node metastasis is associated with allelic loss on chromosome 13q12-13 in esophageal squamous cell carcinoma.
Harada H; Tanaka H; Shimada Y; Shinoda M; Imamura M; Ishizaki K
Cancer Res; 1999 Aug; 59(15):3724-9. PubMed ID: 10446988
[TBL] [Abstract][Full Text] [Related]
35. Ki-ras gene mutations, LOH of the APC and DCC genes, and microsatellite instability in primary colorectal carcinoma are not associated with micrometastases in pericolonic lymph nodes or with patients' survival.
Zauber NP; Wang C; Lee PS; Redondo TC; Bishop DT; Goel A
J Clin Pathol; 2004 Sep; 57(9):938-42. PubMed ID: 15333653
[TBL] [Abstract][Full Text] [Related]
36. BRCA1 gene mutation and loss of heterozygosity on chromosome 17q21 in primary prostate cancer.
Uchida T; Wang C; Sato T; Gao J; Takashima R; Irie A; Ohori M; Koshiba K
Int J Cancer; 1999 Feb; 84(1):19-23. PubMed ID: 9988226
[TBL] [Abstract][Full Text] [Related]
37. Loss of heterozygosity (LOH), malignancy grade and clonality in microdissected prostate cancer.
Hügel A; Wernert N
Br J Cancer; 1999 Feb; 79(3-4):551-7. PubMed ID: 10027329
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
[TBL] [Abstract][Full Text] [Related]
39. Colorectal carcinomas with high microsatellite instability: defining a distinct immunologic and molecular entity with respect to prognostic markers.
Edmonston TB; Cuesta KH; Burkholder S; Barusevicius A; Rose D; Kovatich AJ; Boman B; Fry R; Fishel R; Palazzo JP
Hum Pathol; 2000 Dec; 31(12):1506-14. PubMed ID: 11150376
[TBL] [Abstract][Full Text] [Related]
40. [Genetic alterations and transformations in development and establishment of uterine endometrial carcinomas].
Inoue M
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):751-62. PubMed ID: 8371006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
